My Locations
About Me
I realized during a biology class in college that I could use my interest in science to help make a difference in people’s lives. It drove my decision to pursue a career in medicine. I realized early in medical school that I wanted to spend my career trying to understand cancer, how to fight it and caring for patients who have it. As a medical oncologist with Duke Cancer Center, I specialize in cancers of the chest, including lung cancer and mesothelioma. Working closely with my patients, getting to know them personally and understanding their values and goals, allows me to develop individualized care and treatment plans for each one. The most rewarding part of my work is developing long term relationships with my patients and their families throughout their cancer journeys. I am motivated and inspired by how my patients live their lives everyday.
- Associate Professor of Medicine, Medicine, Medical Oncology 2023
- Member of the Duke Cancer Institute, Duke Cancer Institute 2018
Call for an Appointment
Areas of Expertise
- Lung Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
- Mesothelioma
- Metastatic Brain and Spine Tumors
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
In the News
Loading
Loading
Clinical Focus and Research
-
A082101 STAGE I-IIIA PLEURAL MESOTHELIOMAIRB# PRO00113814 , NCT# NCT05647265
-
AbelZeta_CTIL051 (Non-Small Cell Lung Cancer)IRB# PRO00112188 , NCT# NCT05676749
-
IMM1104-101 for NSCLC with a Ras MutationIRB# PRO00114623 , NCT# NCT05585320
-
Zai Refractory SCLC (Small Cell Lung Cancer)IRB# PRO00114821 , NCT# NCT06179069
- C-TIL051 in Anti-PD1 Resistant Metastatic Non-Small Cell Lung Cancer awarded by AbelZeta Inc. 2024 - 2029
- Vaios, Eugene J., Rachel F. Shenker, Peter G. Hendrickson, Zihan Wan, Donna Niedzwiecki, David Carpenter, Warren Floyd, et al. “Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain Metastases.” JAMA Netw Open 8, no. 4 (April 1, 2025): e254347. https://doi.org/10.1001/jamanetworkopen.2025.4347.
- Wood, Cameron, Liliana Lyniv, James M. Isaacs, Jacob M. Kaufman, Eziafa I. Oduah, Jeff Clarke, Jeffrey Crawford, et al. “Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis.” J Immunother Cancer 13, no. 2 (February 4, 2025). https://doi.org/10.1136/jitc-2024-010395.
- Sands, Jacob M., Stéphane Champiat, Horst-Dieter Hummel, Kelly G. Paulson, Hossein Borghaei, Jean Bustamante Alvarez, David P. Carbone, et al. “Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.” Cancer 131, no. 3 (February 1, 2025): e35738. https://doi.org/10.1002/cncr.35738.
- Isaacs, J., and J. Clarke. “Lung cancer.” In Genomic and Precision Medicine: Oncology, Third Edition, 123–61, 2022. https://doi.org/10.1016/B978-0-12-800684-9.00006-X.
- DeVito, N., M. A. Morse, B. Hanks, and J. M. Clarke. “Immune Checkpoint Combinations with Inflammatory Pathway Modulators.” In Current Cancer Research, 219–41, 2018. https://doi.org/10.1007/978-3-319-63757-0_8.
- Lee, J. I., S. Y. Jung, J. S. Yug, E. K. Chung, V. L. Keedy, T. M. Bauer, J. M. Clarke, et al. “POPULATION PHARMACOKINETICS OF A NOVEL TGF-BETA RECEPTOR I KINASE INHIBITOR VACTOSERTIB IN PATIENTS WITH ADVANCED-STAGE SOLID TUMORS.” In CLINICAL PHARMACOLOGY & THERAPEUTICS, 105:S103–S103. WILEY, 2019.
- Tan, Irena, Tom Stinchcombe, Neal E. Ready, Michael B. Datto, Rebecca J. Nagy, Lin Gu, and Jeffrey Melson Clarke. “Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study.” In Journal of Clinical Oncology, 36:e21222–e21222. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e21222.
- Patel, Sandip Pravin, Scott Morris, Young Kwang Chae, and Jeffrey Melson Clarke. “RNA turbulence by tumor type: Overexpression of actionable mRNA signaling pathways by histology.” In Journal of Clinical Oncology, 35:e23213–e23213. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.e23213.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- AbbVie, Inc.
- Amgen
- Biothera
- Blackdiamond
- Bristol-Myers Squibb (BMS)
- CDR Life
- Coherus
- Cornerstone Specialty Network
- G1 Therapeutics, Inc.
- Merck
- Synthekine